Prevacid, Lansoprazole News

Upstate New Yorkers who take the brand-name prescription drug Prevacid for treating heartburn and acid reflux have a significant opportunity to save by switching to the drug's generic equivalent or over-the-counter version now that the Prevacid patent has expired, according to Excellus BlueCross BlueShield .

PRINCETON,A N.J The generics arm of Swiss pharmaceutical company Novartis has launched an authorized generic version of a gastroesophageal reflux disease drug.

PITTSBURGH The Food and Drug Administration has given two companies approval for a generic version of a drug used to treat gastroesophageal reflux disease.

A complete list of all headlines and biomedical stock developments can be found on BioMedReports.Com On 11/10/09, Teva Pharmaceutical Industries Ltd.

Novartis announced the availability of PrevacidA 24HR over-the-counter in pharmacies and retail stores across the US to treat frequent heartburn.

Main Category: Litigation / Medical Malpractice Also Included In: Pharma Industry / Biotech Industry Article Date: 11 Nov 2009 Teva Pharmaceutical Industries Ltd.

Mylan Inc. has announced that its privately held Indian subsidiary, Matrix Laboratories Limited, has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Lansoprazole Delayed-release Capsules, 15 mg and 30 mg.

New Study Results Analyzed The Use Of KAPIDEX For Nighttime Heartburn In Adults With Non-Erosive GERD Main Category: Acid Reflux / GERD Also Included In: Clinical Trials / Drug Trials ; Pharma Industry / Biotech Industry Article Date: 27 Oct 2009 - 1:00 PDT New data being presented at the American College of Gastroenterology 2009 Annual Scientific ...

Helicobater pylori , a bacteria implicated in peptic ulcers and gastritis, was eradicated in 95 percent patients who took a 7-day course of combination therapy with levofloxacin, omeprazole, nitazoxanide and doxycycline compared to eradication in only 80.9 percent of patients on lansoprazole, amoxicillin and clarithromycin for seven days.

Medication Update Benzyl alcohol combats head lice A new prescription medication for the treatment of head-lice infestation has been approved by the FDA for patients age 6 months and older.

Medication Update Benzyl alcohol combats head lice A new prescription medication for the treatment of head-lice infestation has been approved by the FDA for patients age 6 months and older.

NEW Abstract OBJECTIVE: To assess the possible involvement of CYP2C19 in the metabolism of lansoprazole in vivo.

For heart disease, stroke patients and people at risk of a stroke, the clot-preventing drug Plavix is a lifesaver.

Fast-Track peer review is available for those papers requiring immediate review .

Nursingcenter.com Exclusively searches the complete text articles from the 50 leading nursing journals available on NursingCenter, including more than 900 continuing education activities, clinical resources and drug updates contained within this website.

Increasing resistance to clarithromycin and nitroimidazole is the main cause of failure in the Helicobacter pylori eradication.

Below is a summary of updates to the BioMedReports.com database of over 200 entries included in the FDA and Clinical Trial Calendars .

Novartis has announced that Prevacid 24HR has been approved by the FDA as the first OTC Proton Pump Inhibitor for the treatment of frequent heartburn since 2003.

Lansoprazole is a proton pump inhibitor which powerfully suppresses gastric acid production and is widely prescribed for chronic use in gastroesophageal reflux disease.

A new study has added to the concern that commonly used proton-pump inhibitors may interfere with Plavix in people who have coronary artery disease.